Evidence map›Paper›PMID 30228705›Full record

ArticleMissouri medicine

Imaging in Prostate Cancer: Magnetic Resonance Imaging and Beyond.

Daniel R Ludwig, Tyler J Fraum, Kathryn J Fowler, Joseph E Ippolito

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Daniel R LudwigDaniel R. Ludwig, MD, Radiology Resident, at Washington University School of Medicine, St. Louis, Missouri.
Tyler J FraumTyler J. Fraum, MD, Radiology Resident, at Washington University School of Medicine, St. Louis, Missouri.
Kathryn J FowlerKathryn J. Fowler, MD, Director, Abdominal and Pelvic MRI, at Washington University School of Medicine, St. Louis, Missouri.
Joseph E IppolitoJoseph E. Ippolito, MD, PhD, Medical Director, Center for Clinical Imaging Research at Washington University School of Medicine, St. Louis, Missouri.
Washington University in St. Louis · USSt. Joseph Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Imaging is becoming critical for guiding management decisions in prostate cancer (PCa) both at initial diagnosis and at recurrence. Multiparametric magnetic resonance imaging (mpMRI) and positron emission tomography (PET) of the prostate have proven valuable in the detection and localization of aggressive disease. Therefore, understanding the indications for mpMRI, imaging techniques and interpretation, limitations of current imaging approaches, and utility of PET and simultaneous PET/MRI has become increasingly important.

Indexed as

HumansImage Interpretation, Computer-AssistedMagnetic Resonance ImagingMaleMultimodal ImagingPositron-Emission TomographyProstateProstatic Neoplasms

Identifiers

PMID30228705
PMCPMC6139856
OpenAlexW3005732430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.